U.S. Contract Research Organization (CROs) Market | Coherent Market Insights - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

U.S. Contract Research Organization (CROs) Market | Coherent Market Insights

Description:

Read here the latest updates on the U.S. Contract Research Organization (CROs) Market published by the CMI team. – PowerPoint PPT presentation

Number of Views:13
Date added: 18 August 2020
Slides: 12
Provided by: adwaitcoherent

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: U.S. Contract Research Organization (CROs) Market | Coherent Market Insights


1
Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • Covid-19 Impact Tracker

2
  • U.S. CONTRACT RESEARCH ORGANIZATIONS (CROS)
    MARKET ANALYSIS
  • U.S. Contract Research Organization (CROs)
    Market, by Service Type (Drug Discovery,
    Preclinical studies, Early Phase I IIa, Phase
    IIa III, Phase IIIb IV, Drug Development,
    Medical Coding and Writing, Monitoring, Clinical
    Data Management, Bio-statistics, Site Management,
    Protocol Development, and Biomarker Discovery),
    by Therapeutic Application (Oncology,
    Cardiovascular Diseases, Central Nervous System
    Diseases, Infectious Diseases, Metabolic
    Disorders, Immunological Disorders, Respiratory
    Disorders, and Others), and by Size of CRO (Small
    Size, Medium Size, and Large Size) - Size, Share,
    Outlook, and Opportunity Analysis, 2019 - 2027

3
  • The U.S. Contract Research Organization (CROs)
    Market, by Service Type (Drug Discovery,
    Preclinical studies, Early Phase I IIa, Phase
    IIa III, Phase IIIb IV, Drug Development,
    Medical Coding and Writing, Monitoring, Clinical
    Data Management, Bio-statistics, Site Management,
    Protocol Development, and Biomarker Discovery),
    by Therapeutic Application (Oncology,
    Cardiovascular Diseases, Central Nervous System
    Diseases, Infectious Diseases, Metabolic
    Disorders, Immunological Disorders, Respiratory
    Disorders, and Others), and by Size of CRO (Small
    Size, Medium Size, and Large Size), is estimated
    to be valued at US 12,174.4 million in 2019,
    and is expected to exhibit a CAGR of 9.4, during
    the forecast period (2019-2027), as highlighted
    in a new report published by Coherent Market
    Insights.

4
  • Globally, there are several healthcare IT
    companies, which develop and modify clinical
    trial management software. There is availability
    of customized software to manage clinical trials
    data according to client requirement and study
    protocol. For instance, according to the study
    conducted by the University of Minnesota and
    University of Michigan in 2018, all the companies
    that conduct clinical trials use OnCore clinical
    trial management system, which offers functional
    features such as Clinical Research Management,
    Study Setup, eCRFs, Financials, Visit Tracking
    Data Capture, Study Data Management, and Revenue
    Management. This is expected to be one of the
    important factors expected to drive growth of the
    clinical trial management market over the
    forecast period.Browse 09 Market Data Tables and
    27 Figures spread through 301 Pages and in-depth
    TOC on " U.S. Contract Research Organization
    (CROs) Market, by Service Type (Drug Discovery,
    Preclinical studies, Early Phase I IIa, Phase
    IIa III, Phase IIIb IV, Drug Development,
    Medical Coding and Writing, Monitoring, Clinical
    Data Management, Bio-statistics, Site Management,
    and Protocol Development, and Biomarker
    Discovery), by Therapeutic Application
    (Oncology, Cardiovascular Diseases, Central
    Nervous System Diseases, Infectious Diseases,
    Metabolic Disorders, Immunological Disorders,
    Respiratory Disorders, and Others), and by Size
    of CRO (Small Size, Medium Size, and Large Size),
    - Global Forecast to 2027"

5
  • Growth of the U.S. contract research organization
    (CROs) market is largely driven by increased
    research development expenditure and increasing
    outsourcing. This has attributed to shift in the
    industry focusing towards development of
    therapeutics for rare diseases, as more
    biopharmaceutical manufacturers have increased
    focus towards rare diseases. Therefore,
    increasing research and development expenditure
    in the healthcare sector is a major factor that
    is expected to drive growth of the U.S. contract
    research organization (CROs) market during the
    forecast period.
  • For instance, according to the Pharmaceutical
    Research and Manufacturers of America (PhRMA),
    2018, overall research and development spending
    of pharmaceutical and biotechnology companies was
    around US 62.2 billion in 2018 compared to US
    55.8 billion in 2017, which was majority of all
    biopharmaceutical RD spending in the U.S. This
    increasing research and development expenditure
    has led to an increase in number of drug
    approvals in the recent past. For instance,
    according to the U.S. FDA reports, around 59
    novel drugs were approved in 2018 as compared to
    46 drugs in 2017. Adoption of inorganic
    strategies such as acquisitions and
    collaborations by major players in CRO market is
    expected to drive the U.S. contract research
    organization (CROs) market.

6
Key Takeaways of the U.S. Contract Research
Organization (CROs) Market
  • The U.S. contract research organization (CROs)
    market is expected to exhibit a CAGR of 9.4
    during the forecast period (2019-2027), owing to
    increasing demand for specialized clinical trial
    services and increasing number of clinical trials
    is expected to drive the Early Phase I IIa
    segment growth during the forecast period. For
    instance, in 2018, LabCorp introduced a dedicated
    offering for biotech, medical device, and
    diagnostics companies. The new service offering
    comprises development services, including
    non-clinical and first-in-human studies, Phase I
    development, central laboratory services, and
    regulatory and market access consulting.
  • Technological advancement in the field of
    clinical research to improve efficiency and
    efficacy of clinical trials is expected to drive
    the monitoring segment growth in the U.S.
    contract research organization (CROs) market
    during the forecast period. For instance, in
    February 2019, IQVIA Holdings Inc. launched IQVIA
    RIM Smart, an integrated, cloud-based, end-to-end
    regulatory information management solution for
    the management of a product portfolios complete
    regulatory lifecycle. The system is expected to
    increase speed, efficiency, and improve
    compliance performance.

7
  • Major players operating in the U.S. contract
    research organization (CROs) market include
    Laboratory Corporation of America Holdings
    (Covance), IQVIA, Paraxel International
    Corporation, Syneos Health, PRA Health Sciences,
    Charles River Laboratoires International Inc.
    (CRL), Pharmaceutical Product Development (PPD),
    ICON Public Limited Corporation, Wuxi Apptec,
    Medpace Holdings, Inc, Medidata Solutions, Inc.,
    Theorem Clinical Research, Pharmaron, Envigo,
    Clinipace, CMIC Holdings Co., Ltd, EPS
    International, Synteract, CROMSOURCE, Pharm-Olam,
    Linical Accelovance, Accumedix, Inc., AlcheraBio
    LLC, Amarex Clinical Research LLC, Arianne
    Corporation, Absolute Research Solutions,
    BioClinica Inc., BioPharma Services Inc.,
    Neurovasc Preclinical Services, Inc., PSI, WCCT
    Global Inc., RHO, Inc., CATO Research LLC,
    Spaulding Clinical Research, Celerion,
    Clindatrix, Inc., Comparative Biosciences, Inc.,
    Axiom Real-Time Metrics, CPC Clinical Research,
    Axis Clinicals LLC, DP Clinical, Egeen Inc.,
    Grayline, Cmed, Integrium, LLC, MedTrials, Novum,
    Shin Nippon Biomedical Laboratories, Ltd., KPS
    Life, Pinnacle Research Group, LLC Promedica
    International., Alta Science, Prometrika, LLC,
    4clinics, and Premier Research.

8
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//www.coherentmarketinsights.com/
    market-insight/us-contract-research-organizations-
    market-3179

9
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

10
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

11
Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com